Clarus Corporation Announces Nasdaq Delisting Effective October 5, 2004
02 10월 2004 - 8:35AM
PR Newswire (US)
Clarus Corporation Announces Nasdaq Delisting Effective October 5,
2004 STAMFORD, Conn., Oct. 1 /PRNewswire-FirstCall/ -- Clarus
Corporation (NASDAQ:CLRS) today announced that the Nasdaq Listing
Qualifications Panel (the "Panel") today notified the Company that
the Company's securities will be delisted from the Nasdaq National
Market effective with the open of business on Tuesday, October 5,
2004. The notice follows the Company's disclosure on September 30,
2004, that it had terminated its previously announced negotiations
to acquire a significant operating company. As a result of the
termination of such negotiations, the Company was unable to fulfill
previously disclosed conditions imposed by the Panel for the
Company's securities to remain listed on the Nasdaq National
Market. Because the delisting of the Company's securities from
Nasdaq is being made pursuant to Marketplace Rules 4300 and
4330(a)(3), the Company's securities are not eligible for immediate
quotation on the OTC Bulletin Board (the "OTCBB") or the Pink
Sheets Electronic Quotation Service (the "Pink Sheets") and
application for listing must be made by a market-maker using the
standard listing procedures. The Company has not determined whether
it intends at a future date to coordinate with a market-maker in
the Company's securities in order to initiate trading of the
Company's common stock on either the OTCBB or the Pink Sheets.
However, the Company fully intends to remain compliant with its
reporting requirements under the Securities Exchange Act of 1934,
as amended (the "Exchange Act"). The Company's common stock is
currently subject to acquisition restrictions in order to help
assure the preservation of its net operating loss carry-forwards.
The Company's certificate of incorporation generally restricts
direct and indirect acquisitions of its equity securities if such
acquisition will affect the percentage of the Company's capital
stock owned by a 5% stockholder, as defined in the certificate of
incorporation. This press release contains forward-looking
statements within the meaning of the Securities Act of 1933 and the
Exchange Act. Information in this release includes Clarus' beliefs,
expectations, intentions and strategies regarding Clarus and its
future. Assumptions relating to the forward-looking statements
involve judgments with respect to, among other things, future
economic, competitive and market conditions, and future business
decisions all of which are difficult or impossible to predict
accurately and many of which are beyond our control. Actual results
could differ materially from those projected in the forward-looking
statements as a result of certain risks. All forward-looking
statements contained in this release are based on information
available to Clarus as of the date of this release and Clarus
assumes no obligation to update the forward-looking statements
contained herein. DATASOURCE: Clarus Corporation CONTACT: Nigel
Ekern of Clarus Corporation, +1-203-428-2000 Web site:
http://www.claruscorp.com/ Company News On-Call:
http://www.prnewswire.com/comp/133360.html
Copyright
Clarus Therapeutics (MM) (NASDAQ:CLRS)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Clarus Therapeutics (MM) (NASDAQ:CLRS)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Clarus Therapeutics (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Clarus (MM) News Articles